and steady. Additionally, ThaiBMA offers discount on bond registration fee.? Vorapol said. All businesses either listed or non-listed firms are welcome to join the project launching event, free of
IP_AC/001/2563 February 24, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited
, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like
, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like
Ref.No.IVL001/08/2019 8th August 2019 President The Stock Exchange of Thailand Subject: Acquisition of Integrated Oxides and Derivatives Businesses/ Assets Enclosure: Information concerning the Acquisition of
9.9% compared to total shareholders’ equity as at 31 December 2017, mainly from Bt239.95mn of dividend payment, Bt187.02mn of treasury stock, and Bt294.58mn of net profit in 2018. Key Financial Ratio
9.9% compared to total shareholders’ equity as at 31 December 2017, mainly from Bt239.95mn of dividend payment, Bt187.02mn of treasury stock, and Bt294.58mn of net profit in 2018. Key Financial Ratio
-Translation- NO. ED-MD2020-0009 March 12th, 2020 Subject: Notification of Acquisition Assets To: Director and General Manager The Stock Exchange of Thailand Enclosed Report Eureka Design Public
Microsoft Word - letY17EMD&A .doc (Translation) 23rd February 2018 Subject: Management Discussion and Analysis (MD&A) of year 2017 To: Managing Director of the Stock Exchange of Thailand Business
Microsoft Word - Final_Eng_MD&A Q1'18.docx (Translation) May 15, 2018 Ref: SET-2018-012 Re: Management Discussion and Analysis for Quarter 1’ 2018 Attn. to: President The Stock Exchange of Thailand